No timeline for new late-stage prostate cancer treatment in Manitoba
September of last year, Health Canada gave a new prostate cancer treatment approval for patients with advanced metastatic cases.
It's called PLUVICTO (lutetium (177lu) vipivotide tetraxetan injection) which uses a radioactive particle to attack a certain type of cancer protein. But doctors say there are hurdles ahead for eligible patients to access the treatment, as its approval is just step one.
Prostate cancer is one of the most commonly diagnosed cancers in men. In 80 per cent of cases, the cancer cells have a surface protein called prostate-specific membrane antigen or PSMA. PSMA is the biomarker or target for PLUVICTO.
"I know that our nuclear medical physicians are extremely aware of this,” said Dr. Piotr Czaykowski, a medical oncologist at CancerCare Manitoba. “We have regular conversations with them about this. We know they're keen to try and implement this as soon as it’s something we can implement."
Czaykowski told CTV News this type of technology is already used in the province for a rare type of cancer called neuroendocrine tumour but getting PLUVICTO out to late-stage prostate cancer patients through the public system will take more time.
"Right now where this sits, is there are negotiations underway to establish a price and once that's in place then we have the opportunity to start trying to provide this," he said.
A provincial spokesperson tells CTV News, PLUVICTO has also received a positive recommendation from the Canadian Agency for Drugs and Technologies in Health (CADTH) but it still needs to undergo national negotiations through the panCanadian Pharmaceutical Alliance.
“Only after those negotiations are completed and an agreement is in place with the manufacturer, will Manitoba list the product in the oncology drug formulary,” reads the written statement.
Although it’s not available publicly, Canadians can choose to pay out of pocket for the treatment. At a private clinic in Burnaby, B.C., two patients received PLUVICTO treatments this week.
"The way we describe this is we see what we treat and we treat what we can see," said Dr. Philip Cohen, a nuclear medicine specialist and the medical director at INITIO Medical.
He said the price for the compound, whether being bought by the government or a patient, is $27,000 a dose.
"What I am hopeful for is, as more compounds will make it through the approval process, the cost will plummet and hopefully will become more affordable," said Cohen.
While optimistic for what nuclear treatments might be able to accomplish in the cancer realm, he points out another major issue that may make accessing this type of treatment difficult in Canada. A Positron Emission Tomography or PET scan is required to screen patients.
"There's probably an adequate number in Quebec but outside Quebec there's real limitations to access to pet scanners,” he said.
According to Shared Health there is only one PET scanner in Manitoba at Health Sciences Centre.
Czaykowski says while PLUVICTO is not a home run or a cure, it will be well worth offering to eligible late-stage prostate cancer patients.
"In the studies that have been done, and there was a large trial where half the patients got this therapy and the other half didn't, those who got the therapy lived about five months longer," he explained.
Adding, once there’s the science to support it, there is the potential for the agent to be used earlier during the course of treatment.
CTVNews.ca Top Stories
Young people 'tortured' if stolen vehicle operations fail, Montreal police tell MPs
One day after a Montreal police officer fired gunshots at a suspect in a stolen vehicle, senior officers were telling parliamentarians that organized crime groups are recruiting people as young as 15 in the city to steal cars so that they can be shipped overseas.
'It was joy': Trapped B.C. orca calf eats seal meat, putting rescue on hold
A rescue operation for an orca calf trapped in a remote tidal lagoon off Vancouver Island has been put on hold after it started eating seal meat thrown in the water for what is believed to be the first time.
Man sets self on fire outside New York court where Trump trial underway
A man set himself on fire on Friday outside the New York courthouse where Donald Trump's historic hush-money trial was taking place as jury selection wrapped up, but officials said he did not appear to have been targeting Trump.
Sask. father found guilty of withholding daughter to prevent her from getting COVID-19 vaccine
Michael Gordon Jackson, a Saskatchewan man accused of abducting his daughter to prevent her from getting a COVID-19 vaccine, has been found guilty for contravention of a custody order.
Mandisa, Grammy award-winning 'American Idol' alum, dead at 47
Soulful gospel artist Mandisa, a Grammy-winning singer who got her start as a contestant on 'American Idol' in 2006, has died, according to a statement on her verified social media. She was 47.
She set out to find a husband in a year. Then she matched with a guy on a dating app on the other side of the world
Scottish comedian Samantha Hannah was working on a comedy show about finding a husband when Toby Hunter came into her life. What happened next surprised them both.
B.C. judge orders shared dog custody for exes who both 'clearly love Stella'
In a first-of-its-kind ruling, a B.C. judge has awarded a former couple joint custody of their dog.
Saskatoon police to search landfill for remains of woman missing since 2020
Saskatoon police say they will begin searching the city’s landfill for the remains of Mackenzie Lee Trottier, who has been missing for more than three years.
Shivering for health: The myths and truths of ice baths explained
In a climate of social media-endorsed wellness rituals, plunging into cold water has promised to aid muscle recovery, enhance mental health and support immune system function. But the evidence of such benefits sits on thin ice, according to researchers.